Cisplatin Inactivation of Caspases Inhibits Death Ligand-induced Cell Death in Vitro and Fulminant Liver Damage in Mice
Open Access
- 1 March 2005
- journal article
- Published by Elsevier BV
- Vol. 280 (11), 10509-10515
- https://doi.org/10.1074/jbc.m413865200
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Critical roles of TRAIL in hepatic cell death and hepatic inflammationJCI Insight, 2004
- TRAIL and apoptosis induction by TNF-family death receptorsOncogene, 2003
- Cisplatin: mode of cytotoxic action and molecular basis of resistanceOncogene, 2003
- A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agentsBritish Journal of Cancer, 2003
- T cells require TRAIL for optimal graft-versus-tumor activityNature Medicine, 2002
- Fas Ligand-Induced ApoptosisAnnual Review of Genetics, 1999
- Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosisNature, 1999
- Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death ReceptorsCell, 1998
- Essential roles of the Fas ligand in the development of hepatitisNature Medicine, 1997
- Cisplatin and DNA repair in cancer chemotherapyTrends in Biochemical Sciences, 1995